secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scholar Rock Holding Corp (SRRK)
CIK:        0001727196
Form:       8-K
Filed at:   2023-04-10T23:59:59+00:00
Accession:  0001157523-23-000532
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Scholar Rock appoints Richard Brudnick to Board of Directors
------------------------------------------------------------

- Richard Brudnick appointed to Board as independent director effective April 6, 2023.
- Board size increased to ten; Brudnick joins Audit Committee; Kristina Burow steps off.
- Brudnick is Chief Business Officer of Prime Medicine; previously at Bioverativ and Biogen.
- Srinivas Akkaraju appointed to Science, Innovation and Technology Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1727196/000115752323000532/0001157523-23-000532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1727196/000115752323000532/a53377626.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-000532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer